← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Creative Medical Technology CELZ $5.92M	–	–	–	–
77	77 DELISTED CERo Therapeutics CERO	–	–	–	–
78	78 Calidi Biotherapeutics CLDI $2.25M	–	–	–	–
79	79 Coya Therapeutics COYA $101M	–	–	–	–
80	80 Caribou Biosciences CRBU $50.5M	–	–	–	–
81	81 DELISTED CARGO Therapeutics CRGX	–	–	–	–
82	DBTX 82 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
83	83 Precision BioSciences DTIL $168M	–	–	–	–
84	84 enGene Therapeutics ENGN $107M	–	–	–	–
85	85 Estrella Immunopharma ESLA $13.7M	–	–	–	–
86	86 FibroBiologics FBLG $7.02M	–	–	–	–
87	87 4D Molecular Therapeutics FDMT $681M	–	–	–	–
88	FRLN 88 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
89	89 DELISTED Generation Bio GBIO	–	–	–	–
90	90 CytoMed Therapeutics GDTC $9.95M	–	–	–	–
91	91 Genenta Science GNTA $34.2M	–	–	–	–
92	GRCL 92 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
93	GRML 93 Greenland Mines Ltd GRML $81.2M	–	–	–	–
94	94 Fractyl Health GUTS $55.7M	–	–	–	–
95	95 Immix Biopharma IMMX $722M	–	–	–	–
96	96 IN8bio INAB $11.8M	–	–	–	–
97	97 MiNK Therapeutics INKT $52.8M	–	–	–	–
98	98 INmune Bio INMB $43M	–	–	–	–
99	99 Century Therapeutics IPSC $263M	–	–	–	–
100	KRBP 100 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–